Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma

Leukemia and Lymphoma

Volumn 54, Issue 3, 2013, Pages 491-496

  Tran, Krystel H ^a   Campbell, Belinda A ^a   Fua, Tsien ^a   MacManus, Michael ^a   Ryan, Gail ^a   Chesson, Brent ^a   Wirth, Andrew ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Lymphomas; Marginal zone lymphoma (MZL); Primary orbital MZL; Radiation therapy

Indexed keywords

ARTIFICIAL TEAR; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; BLURRED VISION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CATARACTOGENESIS; CLINICAL ARTICLE; CONJUNCTIVITIS; DIPLOPIA; DRY EYE; ELECTRON THERAPY; ERYTHEMA; EXOPHTHALMOS; FEMALE; FOLLOW UP; HUMAN; LACRIMATION DISORDER; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MARGINAL ZONE LYMPHOMA; ORBIT CANCER; OVERALL SURVIVAL; PERIORBITAL EDEMA; PRIMARY ORBITAL MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CONJUNCTIVA; EYELIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LACRIMAL APPARATUS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORBITAL NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SKIN DISEASES; TREATMENT OUTCOME;

EID: 84873361958     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.717279     Document Type: Article

References (19)

1. Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood 2009;114: 501-510.
2. Goda JS, Le LW, Lapperrier NJ, et al. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: Effcacy and toxicity. Int J Radiat Oncol Biol Phys 2011;81: e659-e666.
3. Jeganathan VS, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys 2011;79: 650-659.
4. Nam H, Ahn YC, Kim YD, et al. Prognostic signif cance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma. Radiother Oncol 2009: 90: 236-241.
5. SPSS forWindows 17.0. Chicago: SPSS, Inc.: 2008.
6. Pfefer MR, Rabin T, Tsvang L, et al Orbital lymphoma: is it necessary to treat the entire orbit? Int J Radiat Oncol Biol Phys 2004;60: 527-530.
7. Zhou P, Ng AK, Silver B, et al. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 2005;63: 866-871.
8. Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of50 patients. Cancer 2003;98: 865-871.
9. Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int JRadiat Oncol Biol Phys 2003;57: 1382-1391.
10. Bayraktar S, Bayraktar UD, Stefanovic A, et al. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. Br J Haematol 2011;152: 72-80.
11. Le QT, Eulau SM, George TI, et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 2002: 52: 657-663.
12. Bolek TW, Moyses HM, Marcus RB Jr, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999;44: 31-36.
13. Martinet S, Ozsahin M, Belkacemi Y, et al. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003;55: 892-898.
14. Yamashita H, Nakagawa K, Asari T, et al. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol 2008: 87: 412-417.
15. Son SH, Choi BO, Kim G, et al. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Int J Radiat Oncol Biol Phys 2010;77: 86-91.
16. Staford SL, Kozelsky TF, Garrity JA, et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 2001;59: 139-144.
17. Pelloski CE, Wilder RB, Ha CS, et al. Clinicalstage IEA-IIEAorbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol 2001: 59: 145-151.
18. Esik O, Ikeda H, Mukai K, et al. AretrospectiveanalysisofDifferent modalities for treatment of primary orbital non-Hodgkin's lymphomas. Radiother Oncol 1996: 38: 13-18.
19. Kennerdell JS, Flores NE, Hartsock RJ. Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa. Ophthal Plast Reconstr Surg 1999;15: 129-133.